You just read:

Regenicin, Inc. Completes Successful Pre-IND Meeting with Food and Drug Administration (FDA) for its New Autologous Cultured Skin Substitute, NovaDerm®

News provided by

Regenicin, Inc.

01 Nov, 2016, 14:54 ET